Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Bioventus Inc. stock logo
BVS
Bioventus
$5.73
+4.9%
$4.89
$1.01
$6.08
$453.64M0.63185,246 shs222,830 shs
The RealReal, Inc. stock logo
REAL
RealReal
$4.26
+0.9%
$3.50
$1.10
$4.40
$451.34M2.943.25 million shs447,006 shs
Beginner's Guide to Pot Stock Investing Cover

Click the link below and we'll send you MarketBeat's guide to pot stock investing and which pot companies show the most promise.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Bioventus Inc. stock logo
BVS
Bioventus
+8.33%+37.88%+7.91%+24.09%+430.10%
The RealReal, Inc. stock logo
REAL
RealReal
+3.43%+11.94%+18.21%+124.47%+244.49%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Bioventus Inc. stock logo
BVS
Bioventus
3.7194 of 5 stars
3.50.00.00.02.74.21.9
The RealReal, Inc. stock logo
REAL
RealReal
0.3411 of 5 stars
1.21.00.00.01.83.30.6

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Bioventus Inc. stock logo
BVS
Bioventus
3.00
Buy$8.0046.52% Upside
The RealReal, Inc. stock logo
REAL
RealReal
2.38
Hold$3.76-11.01% Downside

Current Analyst Ratings

Latest REAL, RIB, ISX, BVS, and PRSM Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
5/8/2024
Bioventus Inc. stock logo
BVS
Bioventus
Canaccord Genuity Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$7.00 ➝ $8.00
5/8/2024
The RealReal, Inc. stock logo
REAL
RealReal
Wedbush
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOutperform ➝ Outperform$3.00 ➝ $4.50
5/8/2024
The RealReal, Inc. stock logo
REAL
RealReal
Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetEqual Weight ➝ Equal Weight$2.00 ➝ $4.00
5/8/2024
The RealReal, Inc. stock logo
REAL
RealReal
Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$6.00
4/12/2024
The RealReal, Inc. stock logo
REAL
RealReal
UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetNeutral ➝ Neutral$2.30 ➝ $3.70
3/13/2024
Bioventus Inc. stock logo
BVS
Bioventus
Craig Hallum
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$6.00 ➝ $9.00
3/1/2024
The RealReal, Inc. stock logo
REAL
RealReal
Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$6.00
(Data available from 5/10/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Bioventus Inc. stock logo
BVS
Bioventus
$512.34M0.84$1.09 per share5.02$2.80 per share1.95
The RealReal, Inc. stock logo
REAL
RealReal
$549.30M0.81N/AN/A($2.97) per share-1.42

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Bioventus Inc. stock logo
BVS
Bioventus
-$156.23M-$2.52N/A13.65N/A-30.49%2.25%0.62%8/13/2024 (Estimated)
The RealReal, Inc. stock logo
REAL
RealReal
-$168.47M-$1.14N/AN/AN/A-30.67%N/A-26.38%8/13/2024 (Estimated)

Latest REAL, RIB, ISX, BVS, and PRSM Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
3/12/2024Q4 2023
Bioventus Inc. stock logo
BVS
Bioventus
$0.06$0.07+$0.01$0.24$124.84 million$135.42 million
2/29/2024Q4 2023
The RealReal, Inc. stock logo
REAL
RealReal
-$0.19-$0.15+$0.04-$0.09$142.80 million$143.37 million      

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Bioventus Inc. stock logo
BVS
Bioventus
N/AN/AN/AN/AN/A
The RealReal, Inc. stock logo
REAL
RealReal
N/AN/AN/AN/AN/A

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Bioventus Inc. stock logo
BVS
Bioventus
1.66
1.53
1.01
The RealReal, Inc. stock logo
REAL
RealReal
N/A
1.25
1.13

Ownership

Institutional Ownership

CompanyInstitutional Ownership
Bioventus Inc. stock logo
BVS
Bioventus
62.94%
The RealReal, Inc. stock logo
REAL
RealReal
64.73%

Insider Ownership

CompanyInsider Ownership
Bioventus Inc. stock logo
BVS
Bioventus
29.10%
The RealReal, Inc. stock logo
REAL
RealReal
9.34%

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
Bioventus Inc. stock logo
BVS
Bioventus
97079.17 million56.13 millionNot Optionable
The RealReal, Inc. stock logo
REAL
RealReal
3,032105.95 million96.05 millionNot Optionable

RIB, REAL, PRSM, ISX, and BVS Headlines

SourceHeadline
RealReal (NASDAQ:REAL) PT Raised to $4.50RealReal (NASDAQ:REAL) PT Raised to $4.50
americanbankingnews.com - May 10 at 5:16 AM
RealReal First Quarter 2024 Earnings: Revenues Beat Expectations, EPS LagsRealReal First Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags
finance.yahoo.com - May 9 at 9:57 AM
Buy Rating Affirmed: RealReal’s Surpassing Expectations and Strategic TurnaroundBuy Rating Affirmed: RealReal’s Surpassing Expectations and Strategic Turnaround
markets.businessinsider.com - May 8 at 11:57 PM
KeyBanc Reaffirms Their Hold Rating on RealReal (REAL)KeyBanc Reaffirms Their Hold Rating on RealReal (REAL)
markets.businessinsider.com - May 8 at 6:56 PM
RealReal (NASDAQ:REAL) Price Target Raised to $4.50 at WedbushRealReal (NASDAQ:REAL) Price Target Raised to $4.50 at Wedbush
marketbeat.com - May 8 at 12:34 PM
The RealReal, Inc. (NASDAQ:REAL) Q1 2024 Earnings Call TranscriptThe RealReal, Inc. (NASDAQ:REAL) Q1 2024 Earnings Call Transcript
insidermonkey.com - May 8 at 10:12 AM
RealReals (REAL) "Buy" Rating Reaffirmed at Needham & Company LLCRealReal's (REAL) "Buy" Rating Reaffirmed at Needham & Company LLC
marketbeat.com - May 8 at 8:56 AM
Q1 2024 RealReal Inc Earnings CallQ1 2024 RealReal Inc Earnings Call
finance.yahoo.com - May 8 at 8:22 AM
The RealReals (NASDAQ:REAL) Q1 Sales Top Estimates, Next Quarters Growth Looks OptimisticThe RealReal's (NASDAQ:REAL) Q1 Sales Top Estimates, Next Quarter's Growth Looks Optimistic
uk.finance.yahoo.com - May 7 at 10:22 PM
REAL Stock Earnings: RealReal Beats EPS, Beats Revenue for Q1 2024REAL Stock Earnings: RealReal Beats EPS, Beats Revenue for Q1 2024
msn.com - May 7 at 10:22 PM
The RealReal (REAL) Reports Q1 Loss, Tops Revenue EstimatesThe RealReal (REAL) Reports Q1 Loss, Tops Revenue Estimates
zacks.com - May 7 at 7:11 PM
The RealReal: Q1 Earnings SnapshotThe RealReal: Q1 Earnings Snapshot
sfgate.com - May 7 at 5:21 PM
The RealReal Announces First Quarter 2024 ResultsThe RealReal Announces First Quarter 2024 Results
finance.yahoo.com - May 7 at 5:21 PM
The RealReal, Inc. (NASDAQ:REAL) Given Consensus Rating of "Hold" by AnalystsThe RealReal, Inc. (NASDAQ:REAL) Given Consensus Rating of "Hold" by Analysts
americanbankingnews.com - May 7 at 3:14 AM
Heres what Wall Street expects from The RealReals earnings reportHere's what Wall Street expects from The RealReal's earnings report
markets.businessinsider.com - May 7 at 2:14 AM
The RealReal (REAL) To Report Earnings Tomorrow: Here Is What To ExpectThe RealReal (REAL) To Report Earnings Tomorrow: Here Is What To Expect
finance.yahoo.com - May 6 at 10:15 AM
Teens accused of stealing $106,000 worth of merchandise from Bellevue storeTeens accused of stealing $106,000 worth of merchandise from Bellevue store
msn.com - May 4 at 7:36 AM
Head to Head Review: Webuy Global (NASDAQ:WBUY) and RealReal (NASDAQ:REAL)Head to Head Review: Webuy Global (NASDAQ:WBUY) and RealReal (NASDAQ:REAL)
americanbankingnews.com - May 3 at 2:06 AM
20 Pairs of Clogs You’ll Wear Everywhere20 Pairs of Clogs You’ll Wear Everywhere
yahoo.com - April 30 at 10:29 PM
The RealReal: Turnaround Plan Deserves A Vote Of ConfidenceThe RealReal: Turnaround Plan Deserves A Vote Of Confidence
seekingalpha.com - April 30 at 7:26 AM
RealReal (REAL) to Release Quarterly Earnings on TuesdayRealReal (REAL) to Release Quarterly Earnings on Tuesday
americanbankingnews.com - April 30 at 5:52 AM
Style rules from the new Vogue editorStyle rules from the new Vogue editor
msn.com - April 30 at 12:09 AM
9 Best Fashion Apps To Buy, Sell And Upgrade Your Style9 Best Fashion Apps To Buy, Sell And Upgrade Your Style
msn.com - April 29 at 7:08 PM
Vinted Profits As ThredUp And Depop Declare Second-Hand The New CoolVinted Profits As ThredUp And Depop Declare Second-Hand The New Cool
forbes.com - April 29 at 2:07 PM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

All Headlines

Company Descriptions

Bioventus logo

Bioventus

NYSE:BVS
Bioventus Inc., a medical device company, focuses on developing and commercializing treatments that engage and enhance the body's natural healing process in the United States and internationally. The company's product portfolio includes pain treatments, which comprise non-surgical pain injection therapies, as well as peripheral nerve stimulation products, such as Durolane, GELSYN-3, and SUPARTZ for the treatment of knee osteoarthritis and Stimrouter to treat chronic peripheral pain. Its surgical solutions comprise bone graft substitutes that increase bone formation to stimulate bone healing in spinal fusions and other orthopedic surgeries; and ultrasonic products used for precise bone cutting and sculpting, soft tissue management, and tissue debridement, in various surgeries, including minimally invasive applications. The company's product include, Osteoamp, an allograft-derived bone graft for bone grafting procedures; Exponent matrix for posterolateral spine procedures; Purebone for bone grafting procedures; Signafuse bone graft; Interfuse bone graft; Osteomatrix+ synthetic bone graft; Extractor for autologous cell and bone marrow extraction; reficio bone matrix; nexus ultrasonic surgical system; bonescalpel surgical solution; SonaStar for surgical procedures; and SonicOne ultrasonic cleansing and debridement system. The company's restorative therapies include a bone stimulation system and devices to help patients regain leg or hand function due to stroke, multiple sclerosis, or other central nervous system disorders. Its products include exogen, a bone healing system; L300 GO, a foot drop system; H200 rehabilitation system; Vector, a body weight support system; and Bioness integrated therapy system. It developing Talisman pulse generator and receiver for peripheral nerve stimulation. The company was founded in 2011 and is headquartered in Durham, North Carolina.
RealReal logo

RealReal

NASDAQ:REAL
The RealReal, Inc. operates an online marketplace for resale luxury goods in the United State. The company offers various product categories, including women's fashion, men's fashion, jewelry, and watches. It primarily sells products through online marketplace and retail stores. The company was incorporated in 2011 and is headquartered in San Francisco, California.